Accelerator™ Drug Development: Streamlining preclinical pathways for a faster transition to First-in-Human trials
Accelerator™ Drug Development: Streamlining preclinical pathways for a faster transition to First-in-Human trials
ケーススタディをダウンロードして、あるバイオテック企業が Thermo Fisher Scientific の統合型 CDMO/CRO ソリューションを活用し、100万ドルのコスト削減と 12か月の開発期間短縮をどのように実現したかをご覧ください。

Added Date:

2025-06-26

Filters:

Filter Category Filter Values
Specialty
  • Other
Month
  • June
Language
  • Japanese
Capability
  • Clinical trial solutions
Year
  • 2025
Asset Type
  • Case study
Country
  • Japan
Region
  • Asia Pacific (APAC)
Content Category
  • Collateral
Market Category
  • Integrated offering

Country Availability:


()

Gated Form:

None Set